MMP2 and lip and oral cavity carcinoma: CAPE was discovered to suppress oral cancer cell metastasis by modulating matrix metalloproteinase-2 and MAP kinase pathway in another investigation, suggesting that it could be utilized as a chemotherapeutic to prevent oral cancer metastasis [217].